BTN3A1 and systemic lupus erythematosus: To investigate whether expression of BTN3A1 was abnormal in SLE patients and whether expression of BTN3A1 was related to SLE pathogenesis, we examined plasma levels of BTN3A1 and BTN3A1 mRNA expression from PBMCs in SLE patients.